NDC 64011-701 Vyleesi
View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 64011 - Amag Pharmaceuticals, Inc.
- 64011-701 - Vyleesi
Product Packages
NDC Code 64011-701-04
Package Description: 4 SYRINGE in 1 CARTON / .3 mL in 1 SYRINGE (64011-701-01)
NDC Code 64011-701-12
Package Description: 2 SYRINGE in 1 CARTON / .3 mL in 1 SYRINGE (64011-701-01)
Product Details
What is NDC 64011-701?
What are the uses for Vyleesi?
Which are Vyleesi UNII Codes?
The UNII codes for the active ingredients in this product are:
- BREMELANOTIDE ACETATE (UNII: PV2WI7495P)
- BREMELANOTIDE (UNII: 6Y24O4F92S) (Active Moiety)
Which are Vyleesi Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- GLYCERIN (UNII: PDC6A3C0OX)
- WATER (UNII: 059QF0KO0R)
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
- HYDROCHLORIC ACID (UNII: QTT17582CB)
What is the NDC to RxNorm Crosswalk for Vyleesi?
- RxCUI: 2176316 - bremelanotide 1.75 MG in 0.3 mL Auto-Injector
- RxCUI: 2176316 - 0.3 ML bremelanotide 5.83 MG/ML Auto-Injector
- RxCUI: 2176316 - bremelanotide 1.75 MG (equivalent to bremelanotide acetate 1.89 MG) per 0.3 ML Auto-Injector
- RxCUI: 2176321 - vyleesi 1.75 MG in 0.3 mL Auto-Injector
- RxCUI: 2176321 - 0.3 ML bremelanotide 5.83 MG/ML Auto-Injector [Vyleesi]
* Please review the disclaimer below.
Patient Education
Bremelanotide Injection
Bremelanotide injection is used to treat women with hypoactive sexual desire disorder (HSDD; a low sexual desire that causes distress or interpersonal difficulty) who have not experienced menopause (change of life; the end of monthly menstrual periods); who have not had problems with low sexual desire in the past; and whose low sexual desire is not due to a medical or mental health problem, a relationship problem, or medication or other drug use. Bremelanotide injection should not be used for the treatment of HSDD in women who have gone through menopause, in men, or to improve sexual performance. Bremelanotide injection is in a class of medications called melanocortin receptor agonists. It works by activating certain natural substances in the brain that control mood and thinking.
[Learn More]
* Please review the disclaimer below.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".